Showing 1 - 3 results of 3 for search 'M.R. Cooperberg', query time: 0.02s Refine Results
  1. 1
    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset

    Defining intermediate-risk prostate cancer suitable for active surveillance with PSA 10-20ng/ml: Pathological outcome analysis of a population-level dataset by P.E. Lonergan, C.W. Jeong, S.L. Washington, A. Herlemann, P.R. Carroll, M.R. Cooperberg

    Published 2020-07-01
    Get full text
    Article
  2. 2
    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer

    Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer by P.E. Lonergan, S.L. Washington, S. Zhao, J.E. Cowan, H.G. Nguyen, K. Shinohara, M.R. Cooperberg, P.R. Carroll

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer

    Clinical utility of 4Kscore, ExosomeDx and SelectMDx and magnetic resonance imaging for the early detection of high-grade prostate cancer by V. Fasulo, C.M. De la Calle, J.E. Cowan, P.E. Lonergan, M. Maggi, A.J. Gadzinsky, R.A. Yeoung, A. Saita, G. Lughezzani, R. Hurle, P. Casale, M.R. Cooperberg, K. Shinohara, P.R. Carroll, H.G. Nguyen

    Published 2020-10-01
    Get full text
    Article

Search Tools: